{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:47:15Z","timestamp":1769604435495,"version":"3.49.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Dermatomyositis is an autoimmune disease characterized by heterogeneous clinical and histopathologic features. Myositis-specific antibodies and myositis-associated antibodies have been linked to distinct clinical phenotypes, but their relationship with specific histopathologic features is unclear. This study aimed to characterize cutaneous histologic patterns in dermatomyositis patients with known autoantibody profiles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We conducted a retrospective review of patients with positive myositis-specific antibody\/myositis-associated antibody serology, a clinical diagnosis of dermatomyositis, and skin biopsies of lesional dermatomyositis-affected skin. Clinical data were extracted from medical records, and histopathologic features were recorded after masked review by 3 subspecialized dermatopathologists. Associations between antibody subtypes and histopathologic features were analyzed using Fisher exact test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The cohort comprised 30 patients who underwent 47 biopsies between 2009 and 2024. The most prevalent features were vacuolar interface dermatitis (70.4%), dermal mucin (71.1%), and mild superficial perivascular inflammation (81.5%). Perivascular inflammation without associated interface dermatitis was associated with nuclear matrix protein 2 positivity (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). Transcriptional intermediary factor 1\u03b3-positive biopsies were less likely to demonstrate dermal mucin (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). No significant associations were found between antibodies and adnexal inflammation or the type of interface dermatitis (vacuolar or lichenoid).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Variability in skin biopsy findings from dermatomyositis patients with specific autoantibodies is limited. Perivascular inflammation without interface change and an absence of dermal mucin may be more common in patients with nuclear matrix protein 2 and TIF1\u03b3 autoantibodies, respectively. These observations may aid diagnosis in cases with atypical histologic features.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dad.0000000000003158","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:02:09Z","timestamp":1761224529000},"page":"100-106","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Correlation of Dermatopathologic Findings and Autoantibody Subtypes in Dermatomyositis"],"prefix":"10.1097","volume":"48","author":[{"given":"Sheldon","family":"Russell","sequence":"first","affiliation":[{"name":"PathWest Laboratory Medicine, J Block, QEII Medical Centre, Perth, WA, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan T.","family":"Harvey","sequence":"additional","affiliation":[{"name":"PathWest Laboratory Medicine, J Block, QEII Medical Centre, Perth, WA, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Mesbah Ardakani","sequence":"additional","affiliation":[{"name":"PathWest Laboratory Medicine, J Block, QEII Medical Centre, Perth, WA, Australia;"},{"name":"School of Medicine, Notre Dame University, Fremantle, WA, Australia;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Brusch","sequence":"additional","affiliation":[{"name":"PathWest Laboratory Medicine, J Block, QEII Medical Centre, Perth, WA, Australia;"},{"name":"Department of Clinical Immunology, Sir Charles Gairdner Hospital, Perth, WA, Australia;"},{"name":"Centre for Neuromuscular and Neurological Disorders, The University of Western Australia, Perth, WA, Australia; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin A.","family":"Wood","sequence":"additional","affiliation":[{"name":"PathWest Laboratory Medicine, J Block, QEII Medical Centre, Perth, WA, Australia;"},{"name":"School of Medicine, The University of Western Australia, Perth, WA, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"R1-20260127","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/acr.24786","article-title":"Incidence, prevalence, and mortality of dermatomyositis: a population\u2010based cohort study","volume":"75","author":"Kronzer","year":"2023","journal-title":"Arthritis Care Res"},{"key":"R3-20260127","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R4-20260127","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","article-title":"Dermatomyositis: clinical features and pathogenesis","volume":"82","author":"DeWane","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R6-20260127","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"R7-20260127","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/25785826.2018.1531188","article-title":"Clinical significance of myositis-specific autoantibodies","volume":"41","author":"Nakashima","year":"2018","journal-title":"Immunol Med"},{"key":"R8-20260127","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12016-015-8513-8","article-title":"The clinical features of myositis-associated autoantibodies: a review","volume":"52","author":"Gunawardena","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"R9-20260127","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11926-018-0733-5","article-title":"Dermatomyositis clinical and pathological phenotypes associated with myositis-specific autoantibodies","volume":"20","author":"Wolstencroft","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"R10-20260127","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cup.13442","article-title":"Clinical factors associated with cutaneous histopathologic findings in dermatomyositis","volume":"46","author":"Wolstencroft","year":"2019","journal-title":"J Cutan Pathol"},{"key":"R11-20260127","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/DAD.0b013e31818520e1","article-title":"Dermatomyositis: a clinicopathological study of 40 patients","volume":"31","author":"Smith","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"R12-20260127","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3389\/fimmu.2017.00992","article-title":"Dermatomyositis and immune-mediated necrotizing myopathies: a window on autoimmunity and cancer","volume":"8","author":"Aussy","year":"2017","journal-title":"Front Immunol"},{"key":"R13-20260127","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/BOR.0000000000000329","article-title":"Recent advances in dermatomyositis-specific autoantibodies","volume":"28","author":"Fujimoto","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"R14-20260127","doi-asserted-by":"crossref","first-page":"e003901","DOI":"10.1136\/rmdopen-2023-003901","article-title":"Severe gastrointestinal involvements in patients with adult dermatomyositis with anti-NXP2 antibody","volume":"10","author":"Fu","year":"2024","journal-title":"RMD Open"},{"key":"R15-20260127","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1001\/jamadermatol.2019.1668","article-title":"Distinct histopathologic patterns of finger eruptions in dermatomyositis based on myositis-specific autoantibody profiles","volume":"155","author":"Okiyama","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R16-20260127","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/cup.14578","article-title":"Anti-PL-7, anti-Ro\/SSA, anti-Mi-2, and anti-TIF1-\u03b3 correlate with specific patterns of histopathologic features in dermatomyositis: an analysis of 39 skin biopsy specimens from 25 patients","volume":"51","author":"Bennett","year":"2024","journal-title":"J Cutan Pathol"},{"key":"R17-20260127","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaad.2014.12.009","article-title":"Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1\u03b3 antibodies in adults with dermatomyositis","volume":"72","author":"Fiorentino","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R18-20260127","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/DAD.0000000000001765","article-title":"Quantitative assessment of eosinophils in dermatomyositis skin biopsies with correlation of eosinophils to pruritus and other clinical features","volume":"43","author":"Khanna","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"R19-20260127","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1600-0560.2012.01891.x","article-title":"Assessment of the \u2018no eosinophils' rule: are eosinophils truly absent in Pityriasis lichenoides, connective tissue disease, and graft-vs.-host disease?","volume":"39","author":"Sharon","year":"2012","journal-title":"J Cutan Pathol"},{"key":"R20-20260127","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000051611","article-title":"Cutaneous leukocytoclastic vasculitis in dermatomyositis suggests malignancy","volume":"202","author":"Hunger","year":"2001","journal-title":"Dermatology"},{"key":"R21-20260127","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/his.14727","article-title":"Histopathological risk factors for malignancy in dermatomyositis","volume":"81","author":"Pruessmann","year":"2022","journal-title":"Histopathology"},{"key":"R22-20260127","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/cup.14203","article-title":"Do histopathological features correlate with systemic manifestations in dermatomyositis? Analysis of 42 skin biopsy specimens from 22 patients","volume":"49","author":"Shakshouk","year":"2022","journal-title":"J Cutan Pathol"},{"key":"R23-20260127","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/jdv.12215","article-title":"Histopathological diagnosis of graft-versus-host disease of the skin\u2013an interobserver comparison","volume":"28","author":"Ziemer","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:00:28Z","timestamp":1769551228000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003158","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}